Abstract:Background. Glioblastoma multiforme (GBM) is the most aggressive and invasive brain tumor, for which novel prognostic markers and predictors of therapeutic response are urgently needed. We reported previously that levels of peptide-O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1 (PomGnT1) in glioma specimens correlated with tumor grade. However, the prognostic significance of PomGnT1 in glioma patients and its function in GBM progression remain unknown.Methods. Clinical relevance of PomGnT1 in GBM patients' prognosis was analyzed both in a clinically annotated expression dataset of 446 GBM tumor specimens and in 82 GBM tumor samples collected at our institution. The function of PomGnT1 in glioma growth and invasion, and the underlying mechanisms of PomGnT1 regulation were explored in vitro and in vivo.Results. PomGnT1 expression in GBM tissues was closely associated with poor prognosis in GBM patients. Forced overexpression of PomGnT1 in glioblastoma cells impaired cell adhesion and increased their proliferation and invasion in vitro. Subsequent in vivo experiments showed that overexpression of PomGnT1 promoted tumor growth and shortened the survival time of tumor-bearing mice in an orthotopic model. Conversely, stable short hairpin RNA-mediated knockdown of PomGnT1 expression produced opposite effects both in vitro and in vivo. Mechanistic studies revealed that activation of epidermal growth factor receptor (EGFR) resulted in EGFR/extracellular signal-regulated kinase-dependent upregulation of PomGnT1, downregulation of receptor-type protein tyrosine phosphatase beta, and activation of beta-catenin pathway signaling.Conclusion. These findings suggest that PomGnT1 promotes GBM progression via activation of beta-catenin and may serve as a prognostic factor for glioma patient survival as well as a novel molecular target for anticancer therapy in malignant glioma.

Beta1,4-galactosyltransferase V A growth regulator in glioma.

β1,4-Galactosyltransferase V Functions as a Positive Growth Regulator in Glioma

Beta 1,4-Galactosyltransferase V Regulates Self-Renewal of Glioma-Initiating Cell

Β1,4-Galactosyltransferase V Activates Notch1 Signaling in Glioma Stem-Like Cells and Promotes Their Transdifferentiation into Endothelial Cells

Over-expression of beta-1,4-galactosyltransferase V increases the growth of astrocytoma cell line.

Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma.

Over-expression of ?-1,4-galactosyltransferase I, II, and V in Human Astrocytoma

Regulation of the Beta 1,4-Galactosyltransferase I Promoter by E2f1

Down-regulation of β1,4-galactosyltransferase V is a critical part of etoposide-induced apoptotic process and could be mediated by decreasing Sp1 levels in human glioma cells

C1GALT1 high expression enhances the progression of glioblastoma through the EGFR-AKT/ERK cascade

Down-regulation of the Expression of Β1,4-Galactosyltransferase V Promotes Integrin Β1 Maturation

B4GALT3 Promotes Cell Proliferation and Invasion in Glioblastoma

Elevated β1,4-Galactosyltransferase I in Highly Metastatic Human Lung Cancer Cells: IDENTIFICATION OF E1AF AS IMPORTANT TRANSCRIPTION ACTIVATOR

Expression of Β 1,4-Galactosyltransferase Mrna in Human Astrocytomas

β1,6 GlcNAc branches-modified protein tyrosine phosphatase Mu attenuates its tyrosine phosphatase activity and promotes glioma cell migration through PLCγ-PKC pathways

<i>N</i>-acetylglucosaminyltransferase I promotes glioma cell proliferation and migration through increasing the stability of the glucose transporter GLUT1

GSK-3 beta regulates tumor growth and angiogenesis in human glioma cells

Mucin O-glycosylating Enzyme GALNT2 Facilitates the Malignant Character of Glioma by Activating the EGFR/PI3K/Akt/mTOR Axis.

Role of Glycosyltransferase PomGnT1 in Glioblastoma Progression.

High expression of β3GnT8 is associated with the metastatic potential of human glioma

Evaluation of ST6Gal1 expression and clinicopathological significance in human glioma